Universal Detection Technology
(PublicWire) — Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, issued a response Tuesday to a growing interest in the security and emergency response communities to immunize first responders most susceptible to anthrax exposure.
“Immunizing first responders goes hand-in-hand with giving them the necessary tools and training to rapidly detect on-site the presence of anthrax or other deadly biogents and respond appropriately”
The issue was brought to the forefront recently at the annual EMS Today Conference in Baltimore, where Dr. Thomas Waytes, vice president at Emergent BioSolutions, raised the question: How can first responders provide necessary medical treatment following an anthrax attack while preserving their own health and safety?
Nasal swabs taken from the first responders on the scene at Senator Tom Daschle’s office following the anthrax letters on October 15, 2001, reveal that some of them had been exposed to the deadly bioweapon.
In the early stage of an inhalational anthrax outbreak, a 1-day delay in the initiation of chemoprophylaxis and treatment of exposed persons can result in thousands of additional deaths and millions of dollars of additional expenditures. Thus, timely detection of an inhalational anthrax outbreak is critical. Rapid detection is also important for disease outbreaks that result from other bioterrorism agents. UNDT has developed a range of products to accurately test for the presence of anthrax spores as well as other deadly bioagents. The equipment detects the presence of these agents in as little as 3 minutes with no hook effect.
“Immunizing first responders goes hand-in-hand with giving them the necessary tools and training to rapidly detect on-site the presence of anthrax or other deadly biogents and respond appropriately,” said Jacques Tizabi, CEO of Universal Detection Technology.
“The growing threat of bioterrorism is prompting more industries and organizations to adequately equip themselves with the bioagent detection capabilities,” continued Tizabi.
UNDT’s 5-agent bioterrorism detection kits have been used extensively by first responders and private industry throughout the United States. Testing of the kits by the U.S. DoD as well as the United Kingdom military show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered “white powders”. The kits are designed to test for anthrax, botulinum toxin, ricin, plague (Y. Pestis) and SEBs in as little as three minutes.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company’s actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.